Use of telepharmacy for the care of people with chronic communicable diseases: a scoping review
DOI:
https://doi.org/10.33448/rsd-v12i3.40719Keywords:
Telemedicine; Pharmaceutical Services; Communicable diseases.Abstract
Clinical services provided by pharmacists are activities whose objective is to optimize the use of medicines, in order to guarantee their effectiveness and safety. The offer of these services can happen in different scenarios in person or remotely. The Covid-19 pandemic expanded the experience of using telepharmacy for continuity of care for patients with chronic diseases. In this sense, this scoping review analyzes perspectives for the provision of clinical pharmaceutical services, remotely, in the care of people with chronic communicable infections. Methods: The searches were carried out in October 2021, in seven literature sources, using a combination of keywords structured from the PCC acronym, that is, Population (people with chronic communicable diseases, especially hepatitis B), Concept (telemedicine or telepharmacy), Context (clinical services provided by pharmacists, in outpatient clinics, households or community pharmacies). Results: From 428 records identified in the searches, 6 studies were selected according to the eligibility criteria, with examples of different clinical services and evaluation of outcomes such as patient satisfaction, treatment adherence, clinical and economic results. Conclusion: Telepharmacy initiatives can be highly satisfactory, from the point of view of professionals and users, presenting advantages and some limitations. However, few studies were identified in which the pharmacist works in the monitoring of people with chronic communicable diseases. Thus, it is important to conduct implementation studies and methodologically more robust studies that assess the effectiveness and impact of the use of telepharmacy in health systems.
References
Abreu, R. M., da Silva Ferreira, C., Ferreira, A. S., Remor, E., Nasser, P. D., Carrilho, F. J., & Ono, S. K. (2016). Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B. Infectious Diseases and Therapy, 5(1), 53–64. https://doi.org/10.1007/s40121-015-0101-y
Alexander, E., Butler, C. D., Darr, A., Jenkins, M. T., Long, R. D., Shipman, C. J., & Stratton, T. P. (2017). ASHP Statement on telepharmacy. In American Journal of Health-System Pharmacy (Vol. 74, Issue 9, pp. e236–e241). American Society of Health-Systems Pharmacy. https://doi.org/10.2146/ajhp170039
Baldoni, S., Amenta, F., & Ricci, G. (2019). Telepharmacy services: Present status and future perspectives: A review. In Medicina (Lithuania) (Vol. 55, Issue 7). MDPI AG. https://doi.org/10.3390/medicina55070327
Cardoso, C. S., Bandeira, M., Ribeiro, A. L. P., Oliveira, G. L., & Caiaffa, W. T. (2011). Escalas de satisfação com o atendimento às doenças cardiovasculares: CARDIOSATIS usuário e equipe. Ciência & Saúde Coletiva, 16(Ciênc. saúde coletiva, 2011 16 suppl 1), 1401–1407. https://doi.org/10.1590/S1413-81232011000700075
Conselho Federal de Farmácia. (2016). Serviços farmacêuticos diretamente destinados ao paciente, à família e à comunidade contextualização e arcabouço conceitual. 1, 200. https://www.cff.org.br/userfiles/Profar_Arcabouco_TELA_FINAL.pdf
De Araújo, B. C., De Melo, R. C., De Bortoli, M. C., De Alcântara Bonfim, J. R., & Toma, T. S. (2019). How to Prevent or reduce prescribing errors: An evidence brief for policy. Frontiers in Pharmacology, 10(JUN). https://doi.org/10.3389/fphar.2019.00439
Diedrich, L., & Dockweiler, C. (2021). Video-based teleconsultations in pharmaceutical care – A systematic review. In Research in Social and Administrative Pharmacy (Vol. 17, Issue 9, pp. 1523–1531). Elsevier Inc. https://doi.org/10.1016/j.sapharm.2020.12.002
Fensterheim, L. E., Gunn, J. G., Pokuta, K. L., Straszewski, A., & Marks, A. (2015). Initial impact of Telepharmacy on specialty Medication adherence. Value in Health, 18(3), A299. https://doi.org/10.1016/j.jval.2015.03.1743
Gossenheimer, A. N., Rigo, A. P., & Schneiders, R. E. (2020). Organização do serviço de telecuidado farmacêutico como estratégia de combate à COVID-19 no rio Grande do Sul. REAd. Revista Eletrônica de Administração (Porto Alegre), 26(3), 524–535. https://doi.org/10.1590/1413-2311.293.109474
International Pharmaceutical Federation. (2022). Medication review and medicines use review A toolkit for pharmacists 2022 Colophon. https://www.fip.org/file/5100
Léon, A., Cáceres, C., Chausa, P., Martin, M., Codina, C., Rousaud, A., Blanch, J., Mallollas, J., Martinez, E., Blanco, J. L., Laguno, M., Larousse, M., Milinkovic, A., Zamora, L., Canal, N., Miró, J. M., Gatell, J. M., Gómez, E. J., & Garcia, F. (2011). A New Multidisciplinary Home Care Telemedicine System to monitor Stable Chronic Human Immunodeficiency Virus-Infected Patients: A Randomized Study. PloSone, 6(1). https://doi.org/doi:10.1371/journal.pone.0014515.g001
Li, H., Zheng, S., Liu, F., Liu, W., & Zhao, R. (2021). Fighting against COVID-19: Innovative strategies for clinical pharmacists. In Research in Social and Administrative Pharmacy (Vol. 17, Issue 1, pp. 1813–1818). Elsevier Inc. https://doi.org/10.1016/j.sapharm.2020.04.003
Littauer, S. L., Dixon, D. L., Mishra, V. K., Sisson, E. M., & Salgado, T. M. (2017). Pharmacists providing care in the outpatient setting through telemedicine models: A narrative review. In Pharmacy Practice (Vol. 15, Issue 4). Grupo de Investigacion en Atencion Farmaceutica. https://doi.org/10.18549/PharmPract.2017.04.1134
Margusino-Framinan, L., Cid-Silva, P., Castro-Iglesias, Á., Mena-De-Cea, Á., Rodríguez-Osorio, I., Pernas-Souto, B., Vázquez-Rodríguez, P., López-Calvo, S., & Martín-Herranz, I. (2019). Teleconsultation for the Pharmaceutical Care of HIV Outpatients in Receipt of Home Antiretrovirals Delivery: Clinical, Economic, and Patient-Perceived Quality Analysis. Telemedicine and E-Health, 25(5), 399–406. https://doi.org/10.1089/tmj.2018.0041
McNamara, A., Zhao, M., & Lee, S. Y. (2021). Evaluating the primary care clinical pharmacist visit transition to telehealth during the COVID-19 pandemic by comparing medication related problems from telehealth visits and in-person visits. JACCP Journal of the American College of Clinical Pharmacy, 4(8), 914–923. https://doi.org/10.1002/jac5.1487
Ministério da Saúde. (2019). Guia Metodológico para Programas e Serviços em Telessaúde [recurso eletrônico]. http://bvsms.saude.gov.br/bvs/publicacoes/guia_metodologico_programas_telessaude.pdf
Morillo-Verdugo, R., Margusino-Framiñán, L., Monte-Boquet, E., Morell-Baladrón, A., Barreda-Hernández, D., Rey-Piñeiro, X. M., Negro-Vega, E., & Delgado-Sánchez, O. (2020). Spanish society of hospital pharmacy position statement on telepharmacy: Recommendations for its implementation and development. Farmacia Hospitalaria, 44(4), 174–181. https://doi.org/10.7399/fh.11515
Niznik, J. D., He, H., & Kane-Gill, S. L. (2018). Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic review. In Research in Social and Administrative Pharmacy (Vol. 14, Issue 8, pp. 707–717). Elsevier Inc. https://doi.org/10.1016/j.sapharm.2017.10.011
Omboni, S., & Tenti, M. (2019). Telepharmacy for the management of cardiovascular patients in the community. In Trends in Cardiovascular Medicine (Vol. 29, Issue 2, pp. 109–117). Elsevier Inc. https://doi.org/10.1016/j.tcm.2018.07.002
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016). Rayyan-a web and mobile app for systematic reviews. Systematic Reviews, 5(1). https://doi.org/10.1186/s13643-016-0384-4
Peters, M. D. J., Godfrey, C. M., Khalil, H., McInerney, P., Parker, D., & Soares, C. B. (2015). Guidance for conducting systematic scoping reviews. International Journal of Evidence-Based Healthcare, 13(3), 141–146. https://doi.org/10.1097/XEB.0000000000000050
Portaria nº 1136, de 18 de dezembro de 2020. Inclui procedimentos na Tabela de Procedimentos, Medicamentos, Órteses, Próteses e Materiais Especiais do SUS. Diário Oficial da União. https://brasilsus.com.br/index.php/pdf/portaria-no-1-136-3/
Poudel, A., & Nissen, L. (2016). Telepharmacy: a pharmacist's perspective on the clinical benefits and challenges. Integrated Pharmacy Research and Practice, Volume 5, 75–82. https://doi.org/10.2147/iprp.s101685
Queiroz, R. M. P., Pessoa, N. Tavares, & Fonteles, M. M. de F. (2021, December). Implementação do serviço de teleconsulta farmacêutica para pessoas com diabetes mellitus:foco no autocuidado apoiado. Conselho Federal de Farmácia (CFF). Experiências Exitosas de Farmacêuticos No SUS , 7(7), 15–22. https://doi.org/10.14450
Resolução No 727, de 30 de junho de 2022. Dispõe sobre a regulamentação da Telefarmácia. https://www.in.gov.br/en/web/dou/-/resolucao-n-727-de-30-de-junho-de-2022-416502055
Rocha, P. A., & Toma, T. S. (2021). Protocolo: Uma revisão de escopo sobre o uso de telemedicina em serviços farmacêuticos para atenção a pessoas com doenças crônicas transmissíveis. https://doi.org/https://doi.org/10.17605/OSF.IO/JTH23
Segal, E. M., Alwan, L., Pitney, C., Taketa, C., Indorf, A., Held, L., Lee, K. S., Son, M., Chi, M., Diamantides, E., & Gosser, R. (2020). Establishing clinical pharmacist telehealth services during the COVID-19 pandemic. American Journal of Health-System Pharmacy, 77(17), 1403–1408. https://doi.org/10.1093/ajhp/zxaa184
Silva, A. B., da Silva, R. M., da Rocha Ribeiro, G., Guedes, A. C. C. M., Santos, D. L., Nepomuceno, C. C., & Caetano, R. (2020). Three decades of telemedicine in Brazil: Mapping the regulatory framework from 1990 to 2018. In PLoS ONE (Vol. 15, Issue 11 November). Public Library of Science. https://doi.org/10.1371/journal.pone.0242869
Sociedade Brasileira de Farmácia Clínica (2019). Origem da Farmácia Clínica no Brasil, seu desenvolvimento, conceitos relacionados e perspectivas. http://www.farmaciaclinica.org.br/wp-content/uploads/2019/11/Position-Paper.pdf
Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G. Garritty, C., Straus, S. E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. In Annals of Internal Medicine (Vol. 169, Issue 7, pp. 467–473). American College of Physicians. https://doi.org/10.7326/M18-0850
Watson, K. E., Schindel, T. J., Barsoum, M. E., & Kung, J. Y. (2021). COVID the Catalyst for Evolving Professional Role Identity? A Scoping Review of Global Pharmacists’ Roles and Services as a Response to the COVID-19 Pandemic. Pharmacy, 9(2), 99. https://doi.org/10.3390/pharmacy9020099
World Health Organization (2002). WHO Policy Perspectives on Medicines-Promoting rational use of medicines: core components WHO Policy Perspectives on Medicines [Internet]. Geneva; World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/67438/WHO_EDM_2002.3.pdf
World Health Organization (2018). Classification of Digital Health Interventions v 1.0. http://who.int/reproductivehealth/topics/mhealth/en/.
You, A., Kawamoto, J., & Smith, J. P. (2014). A pharmacist-managed telemedicine clinic for hepatitis C care: A descriptive analysis. Journal of Telemedicine and Telecare, 20(2), 99–101. https://doi.org/10.1177/1357633X13519043
Young, J. D., Patel, M., Badowski, M., Mackesy-Amiti, M. E., Vaughn, P., Shicker, L., Puisis, M., & Ouellet, L. J. (2014). Improved virologic suppression with HIV subspecialty care in a large prison system using telemedicine: An observational study with historical controls. Clinical Infectious Diseases, 59(1), 123–126. https://doi.org/10.1093/cid/ciu222
Zhou, C., Pavlakos, R., Clark, M., Jue, V. I., & Clinard, V. B. (2021). Pharmacy Telehealth Services: Perspectives From an Academic Medical Center. In Journal of Pharmacy Practice. SAGE Publications Inc. https://doi.org/10.1177/08971900211030652
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Priscilla Alves Rocha; Tereza Setsuko Toma
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.